Modeling cognitive deficits associated with parkinsonism in the chronic-low-dose mptp-treated monkey

Animal Models of Cognitive Impairment

Volumn , Issue , 2006, Pages 169-180

  Schneider, Jay S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057476566     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (53)

1. Levin, B.E., Llabre, M.M., and Weiner, W.J., Cognitive impairments associated with early Parkinson’s disease, Neurology, 39, 557-561, 1989.
2. Heitanen, M. and Teravainen, H., Cognitive performance in early Parkinson’s disease, Acta Neurol. Scand., 73, 151-159, 1986.
3. Cooper, J.A., Sagar, H.J., Jordan, N., Harvey, N.S., and Sullivan, E., Cognitive impairment in early, untreated Parkinson’s disease and its relationship to motor disability, Brain, 114, 2095-2122, 1991.
4. Owen, A.M., James, M., Leigh, P.N., Summers, B.A., Marsden, C.D., Quinn, N.P., Lange, K.W., and Robbins, T.W., Fronto-striatal cognitive deficits at different stages of Parkinson’s disease, Brain, 115, 1727-1751, 1992.
5. Lees, A.J. and Smith, E., Cognitive deficits in the early stages of Parkinson’s disease, Brain, 106, 257-270, 1983.
6. Taylor, A.E., Saint-Cyr, J.A., and Lang, A.E., Frontal lobe dysfunction in Parkinson’s disease, Brain, 109, 845-883, 1986.
7. Brown, R.G. and Marsden, C.D., “Subcortical dementia”: the neuropsychological evidence, Neuroscience, 25, 363-387, 1988.
8. Boller, F., Passafiume, D., Keefe, N.C. et al., Visuospatial impairments in Parkinson’s disease: role of perceptual and motor factors, Arch. Neurol., 41, 485-490, 1984.
9. Owen, A.M., Iddon, J.L., Hodges, J.R., Summers, B.A., and Robbins, T.W., Spatial and non-spatial working memory at different stages of Parkinson’s disease, Neuropsychologia, 35, 519-532, 1997.
10. Flowers, K.A. and Robertson, C., The effect of Parkinson’s disease on the ability to maintain a mental set, J. Neurol. Neurosurg. Psychiatr., 48, 517-529, 1985.
11. Downes, J.J., Roberts, A.C., Sahakian, B.J., Evenden, J.L., Morris, R.G., and Robbins, T.W., Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson’s disease: evidence for a specific attentional dysfunction, Neuropsychologia, 27, 1329-1343, 1989.
12. Freedman, M. and Oscar-Berman, M., Selective delayed response deficits in Parkinson’s and Alzheimer’s disease, Arch. Neurol., 43, 886-890, 1986.
13. Sharpe, M.H., Distractibility in early Parkinson’s disease, Cortex, 26, 239-246, 1990.
14. Sharpe, M.H., Auditory attention in early Parkinson’s disease: an impairment in focused attention, Neuropsychologia, 30, 101-106, 1992.
15. Owen, A.M., Beksinska, M., James, M., Leigh, P., Summers, B.A. et al., Visuo-spatial memory deficits at different stages of Parkinson’s disease, Neuropsychologia, 31, 627-644, 1993.
16. Owen, A.M., Sahakian, B.J., Semple, J. et al., Visuo-spatial short term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man, Neuropsychologia, 33, 1-24, 1995.
17. Owen, A.M., James, M., Leigh, P.N., Summers, B.A., Marsden, C.D., Quinn, N.P., Lange, K.W., and Robbins, T.W., Fronto-striatal cognitive deficits at different stages of Parkinson’s disease, Brain, 115, 1727-1751, 1992.
18. Bradley, V.A., Welch, J.L., and Dick, V.J., Visuospatial working memory in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatr., 52, 1228-1235, 1989.
19. Postle, B.R., Corkin, S., and Growdon, J.H., Dissociation between two kinds of visual working memory in Parkinson’s disease, Soc. Neurosci. Abstr., 409, 1002, 1993.
20. Partiot, A., Verin, M., Pillon, B. et al., Delayed response tasks in basal ganglia lesions in man: further evidence for a striato-frontal cooperation in behavioural adaptation, Neuropsychologia, 34, 709-721, 1996.
21. Owen, A.M., Cognitive dysfunction in Parkinson’s disease: the role of frontostriatal circuitry, Neuroscientist, 10, 525-537, 2004.
22. Pillon, B., Dubois, B., Bonnet, A.M., Esteguy, M., Guimaraes, J., Vigouret, J.M., Lhermitte, F., and Agid, Y., Cognitive slowing in Parkinson’s disease fails to respond to levodopa treatment: the 15-objects test, Neurology, 39, 762-768, 1989.
23. Cools, R., Barker, R.A., Sahakian, B.J., and Robbins, T.W., L-dopa medication remediates cognitive inflexibility but increases impulsivity in patients with Parkinson’s disease, Neuropsychologia, 41, 1431-1441, 2003.
24. Schneider, J.S., Ferraro, S., Gollomp, S.M., Mancall, E.L., Cambi, F., and Mozley, P.D., Effects of dopamine replacement on cognitive and motor functions in Parkinson’s disease: correlation with [Tc-99m]TRODAT-1 labeling of striatal dopamine transporter sites, Soc. Neurosci. Abstr., 27, 2001.
25. Roeltgen, D.P. and Schneider, J.S., Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys, Behavioural Brain Res., 60, 115-124, 1994.
26. Schneider, J.S. and Kovelowski, C.J., Chronic exposure to low doses of MPTP, I: cognitive deficits in motor asymptomatic monkeys, Brain Res., 519, 122-128, 1990.
27. Schneider, J.S. and Roeltgen, D.P., Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys, Brain Res., 615, 351-354, 1993.
28. Decamp, E. and Schneider, J.S., Attention and executive function deficits in chronic low dose MPTP-treated non-human primates, Eur. J. Neurosci., 20, 1371-1378, 2004.
29. Pillom, B., Deweer, B., Vidhailet, M. et al., Is impaired memory for spatial location in Parkinson’s disease domain specific or dependent on " strategic” processes? Neuropsychologia, 36, 1-9, 1998.
30. Schneider, J.S. et al., Effects of the nicotinic acetylcholine receptor agonist SIB- 1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment, Ann. Neurol., 43, 311-317, 1998.
31. Schneider, J.S., Tinker, J.P., Van Velson, M., Menzaghi, F., and Lloyd, G.K., Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low dose MPTP-treated monkeys, J. Pharmacol. Exp. Ther., 290, 731-739, 1999.
32. Decamp, E. Tinker, J.P., and Schneider, J.S., Attentional cueing reverses deficits in spatial working memory task performance in chronic low dose MPTP-treated monkey, Behavioural Brain Res., 152, 259-262, 2004.
33. Downes, J.J., Roberts, A.C., Sahakian, B.J., Evenden, J.L., Morris, R.G., and Robbins, T.W., Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson’s disease: evidence for a specific attentional dysfunction, Neuropsychologia, 27, 1329-1343, 1989.
34. Voytko, M.L., Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention? Behavioural Brain Res., 75, 13-25, 1996.
35. Witte, E.A. and Marrocco, R.T., Alteration of brain noradrenergic activity in rhesus monkeys affects the alerting component of covert orienting, Psychopharmacology, 132, 315-323, 1997.
36. Amalric, M., Moukhles, H., Nieoullon, A., and Daszuta, A., Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat, Eur. J. Neurosci., 7, 972-980, 1995.
37. Leplow, B., Holl, D., Zeng, L., Herzog, A., Behrens, K., and Mehdorn, M., Spatial behavior is driven by proximal cues even in mildly impaired Parkinson’s disease, Neuropsychologia, 40, 1443-1455, 2002.
38. Yamaguchi, S. and Kobayashi, S., Contributions of the dopaminergic system to voluntary and automatic orienting of visuospatial attention, J. Neurosci., 18, 1869-1878, 1998.
39. Pastor, M.A., Artieda, J., Jahanshani, M., and Obeso, J.A., Time estimation and reproduction is abnormal in Parkinson’s disease, Brain, 115, 211-225, 1992.
40. Roeltgen, D.P. and Schneider, J.S., Chronic low-dose MPTP in nonhuman primates: a possible model for attention deficit disorder, J. Child. Neurol., 6 (Suppl.), S80-S87, 1991.
41. Barkley, R.A., Edwards, G., Laneri, M., Fletcher, K., and Metevia, L., Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD), J. Abnormal Child Psychol., 29, 541-556, 2001.
42. Barnett, R., Maruff, P., Vance, A., Luk, E.S., Costin, J., Wood, C., and Pantelis, C., Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory, Psych. Med., 31, 1107-1115, 2001.
43. Shallice, T., Marzocchi, G.M., Coser, S., Del Savio, M., Meuter, R.F., and Rumiati, R.I., Executive function profile of children with attention deficit hyperactivity disorder, Dev. Neuropsychol., 21, 43-71, 2002.
44. Barkley, R.A., Koplowitz, S., Anderson, T., and McMurray, M.B., Sense of time in children with ADHD: effects of duration, distraction, and stimulant medication, J. Int. Neuropsychol. Soc., 3, 359-369, 1997.
45. Solanto, M.V., Clinical psychopharmacology of AD/HD: implications for animal models, Neurosci. Biobehavioral Rev., 24, 27-30, 2000.
46. Schneider, J.S., Sun, Z.Q., and Roeltgen, D.P., Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys, Pharmacol. Biochem. Behav., 48, 235-240, 1994.
47. Schneider, J.S., Giardiniere, M., and Morain, P., Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys, Neuropsychopharmacology, 26, 176-182, 2002.
48. Schneider, J.S., Tinker, J.P., Menzaghi, F., and Lloyd, G.K., The subtype-selective nicotinic acetylcholine receptor agonist SIB-1553A improves both attention and memory components of a spatial working memory task in chronic low dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys, J. Pharmacol. Experimental Ther., 306, 401-406, 2003.
49. Nestor, P.G. et al., Neuromodulation of attention in schizophrenia, Schizophrenia Bulletin, 16, 424-432, 1990.
50. Stip, E. and Lussier, I., The heterogeneity of memory dysfunction in schizophrenia, Can. J. Psychiatry, 41 (Suppl. 1), 14S-20S, 1996.
51. Hoff, A.L., Neuropsychology in schizophrenia: an update, Curr. Opin. Psychiatry, 16, 149-155, 2003.
52. Johnson-Selfridge, M. and Zalewski, C., Moderator variables of executive functioning in schizophrenia: meta-analytic findings, Schizophrenia Bull., 2, 305-316, 2001.
53. Barch, D.M., Carter, C.S., Braver, T.S. et al., Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia, Arch. Gen. Psychiatry, 58, 280-288, 2001.